Concern about the safety of electric power morcellation for gynecologic surgery led the US Food and Drug Administration (FDA) to issue a safety communication in April 2014 discouraging use of the devices and, in November 2014, to recommend against use of morcellation in perimenopausal and postmenopausal women.1,2 Concern has been raised that these actions may result in performance of a greater number of hysterectomies via laparotomy, with an increased risk of complications.3 We examined trends in the route of hysterectomy, use of electric power morcellators, and prevalence of abnormal pathology before and after the FDA’s guidance.
Wright JD, Chen L, Burke WM, Hou JY, Tergas AI, Ananth CV, Hershman DL. Trends in Use and Outcomes of Women Undergoing Hysterectomy With Electric Power Morcellation. JAMA. 2016;316(8):877-878. doi:10.1001/jama.2016.9432